Spitz’s Genodermatoses: A Clinical Guide to Genetic Skin Disorders, 3rd Edition

This user-friendly and highly visual guide is ideal for dermatologists, pediatricians, and family physicians seeking a comprehensive resource for board preparation and clinical practice.

About the Authors

Written by renowned experts Dr. Joel L. Spitz, Dr. Jennifer L. Hand, and Dr. Jackson Glenn Turbeville, this clinical guide provides complete coverage of complex and challenging inherited disorders, making it an indispensable resource for healthcare professionals.

Key Features

• Over 300 full-color clinical photographs and full-body diagrams to enhance understanding of each syndrome
• Bulleted text summaries of patterns of inheritance, prenatal diagnosis, incidence, age of presentation, pathogenesis, key features, differential diagnosis, laboratory findings, management, and prognosis
• Significantly updated content on genetic mutations, pathogenesis, prognosis, clinical pearls, and management
• New illustrations throughout the book, including coverage of new syndromes and revised names for previously discussed syndromes
• Boxed features that highlight clinical pearls, adding insight and breadth to the material

What’s New in the 3rd Edition

This updated edition includes new and revised content on:

• Epidermolytic Ichthyosis
• Superficial Ichthyosis
• Autosomal Recessive Congenital Ichthyosis
• Pigmentary Mosaicism
• Noonan Syndrome with Multiple Lentigenes
• PIK3CA-Related Overgrowth Spectrum (PROS)
• Multiple Infantile Hemangiomas +- Extracutaneous Disease
• Lynch Syndrome
• Muir-Torre variant
• Kindler Epidermolysis Bullosa

Enrich your learning experience with this comprehensive guide, available in a range of formats to suit your needs.

Product Details

Published by LWW, the 3rd edition of Spitz’s Genodermatoses: A Clinical Guide to Genetic Skin Disorders is available in hardcover format, featuring 464 pages of in-depth information and vibrant illustrations. ISBN-10: 1451116519, ISBN-13: 978-1451116519. Release date: May 25, 2024.